Skip to main content

Post-procedural Care and Complication Management for Prostatic Artery Embolization

  • Chapter
  • First Online:
Prostatic Artery Embolization

Abstract

Prostatic artery embolization (PAE) has an overall good safety profile. Expected side effects are typically related to post-embolic inflammation of the prostate and peri-prostatic tissues. These symptoms are usually self-limited; however, medical treatment can be administered by the interventionalist to increase patient comfort during recovery. Non-target embolization may occur during the procedure and its effects should be recognized. Following the procedure, the interventionalist should be aware of the potential for other complications such as urinary tract infection, urethral obstruction, and radiodermatitis and be able to appropriately manage and triage these complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AUR:

Acute urinary retention

IPSS:

International prostate symptom score

NSAID:

Nonsteroidal anti-inflammatory drug

PAE:

Prostate artery embolization

PVR:

Post-void residual

UTI:

Urinary tract infection

References

  1. Cizman Z, Isaacson A, Burke C. Short- to midterm safety and efficacy of prostatic artery embolization: a systematic review. J Vasc Interv Radiol. 2016;27(10):1487–1493.e1.

    Article  Google Scholar 

  2. Kuang M, Vu A, Athreya S. A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2017;40(5):655–63.

    Article  Google Scholar 

  3. Young S, Golzarian J. Prostatic artery embolization for benign prostatic hyperplasia: a review. Curr Opin Urol. 2018;28(3):284–7.

    Article  Google Scholar 

  4. Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98.

    Article  CAS  Google Scholar 

  5. Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017;40(10):1490–500.

    Article  Google Scholar 

  6. Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266(2):668–77.

    Article  Google Scholar 

  7. Moschouris H, Stamatiou K, Kornezos I, Kartsouni V, Malagari K. Favorable outcome of conservative management of extensive bladder ischemia complicating prostatic artery embolization. Cardiovasc Intervent Radiol. 2018;41(1):191–6.

    Article  Google Scholar 

  8. Gabr AH, Gabr MF, Elmohamady BN, Ahmed A-F. Prostatic artery embolization: a promising technique in the treatment of high-risk patients with benign prostatic hyperplasia. Urol Int. 2016;97(3):320–4.

    Article  CAS  Google Scholar 

  9. Amouyal G, Thiounn N, Pellerin O, Yen-Ting L, Del Giudice C, Dean C, et al. Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016;39(3):367–75.

    Article  Google Scholar 

  10. Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol. 2016;39(10):1372–8.

    Article  Google Scholar 

  11. Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602–5.

    Article  Google Scholar 

  12. Pisco JM, Bilhim T, Duarte M, Santos D. Management of uterine artery embolization for fibroids as an outpatient procedure. J Vasc Interv Radiol. 2009;20(6):730–5.

    Article  Google Scholar 

  13. Isaacson AJ, Bhalakia N, Burke CT. Coil embolization to redirect embolic flow during prostatic artery embolization. J Vasc Interv Radiol. 2015;26(5):768–70.

    Article  Google Scholar 

  14. Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686–1697.e8.

    Article  Google Scholar 

  15. Dreger NM, Degener S, Ahmad-Nejad P, Wöbker G, Roth S. Urosepsis - Ursache, diagnose und therapie. Dtsch Arztebl Int. 2015;112(49):837–47.

    PubMed  PubMed Central  Google Scholar 

  16. Bhatia S, Sinha VK, Kava BR, Gomez C, Harward S, Punnen S, et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol. 2018;29(1):78–84.e1.

    Article  Google Scholar 

  17. Leite LC, de Assis AM, Moreira AM, Harward SH, Antunes AA, Carnevale FC. Prostatic tissue elimination after prostatic artery embolization (PAE): a report of three cases. Cardiovasc Intervent Radiol. 2017;40(6):937–41.

    Article  Google Scholar 

  18. Ghelfi J, Poncet D, Sengel C, Charara S, Delouche A, Guillaume B, et al. Prostatic fragment requiring endoscopic management after prostatic artery embolization for indwelling bladder catheter. Cardiovasc Intervent Radiol. 2018;41(8):1295–7.

    Article  Google Scholar 

  19. Teoh JYC, Chiu PKF, Yee CH, Wong HM, Chan CK, Chan ESY, et al. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. Int Urol Nephrol. 2017;49(2):197–203.

    Article  Google Scholar 

  20. Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol. 2014;37(6):1430–5.

    Article  Google Scholar 

  21. Maclean D, Harris M, Drake T, Maher B, Modi S, Dyer J, et al. Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE). Cardiovasc Intervent Radiol. 2018;41(8):1152–9.

    Article  CAS  Google Scholar 

  22. Isaacson AJ, Hartman TS, Bagla S, Burke CT. Initial experience with balloon-occlusion prostatic artery embolization. J Vasc Interv Radiol. 2018;29(1):85–9.

    Article  Google Scholar 

  23. Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, et al. The UK ROPE Study: efficacy and safety of prostate artery embolisation for benign prostatic hyperplasia. An observational study and propensity matched comparison with transurethral resection of the prostate. BJU Int. 2018;122(2):270–82.

    Article  Google Scholar 

  24. Carnevale FC, Soares GR, de Assis AM, Moreira AM, Harward SH, Cerri GG. Anatomical variants in prostate artery embolization: a pictorial essay. Cardiovasc Intervent Radiol. 2017;40(9):1321–37.

    Article  Google Scholar 

  25. de Assis AM, Moreira AM, de Paula Rodrigues VC, Harward SH, Antunes AA, Srougi M, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol. 2015;38(4):855–61.

    Article  Google Scholar 

  26. Bhatia S, Sinha V, Bordegaray M, Kably I, Harward S, Narayanan G. Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile. J Vasc Interv Radiol. 2017;28(5):656–664.e3.

    Article  Google Scholar 

  27. Carnevale FC, Da Motta-Leal-Filho JM, Antunes AA, Baroni RH, ASZ M, LMO C, et al. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol. 2013;24(4):535–42.

    Article  Google Scholar 

  28. Kisilevzky N, Laudanna Neto C, Cividanes A. Ischemia of the Glans Penis following prostatic artery embolization. J Vasc Interv Radiol. 2016;27(11):1745–7.

    Article  Google Scholar 

  29. Kably I, Richardson A, Naidu A, Sinha V, Bhatia S. Coil embolization of penile arterial collaterals during PAE efficacy and safety profile. J Vasc Interv Radiol. 2018;29(4):S8.

    Article  Google Scholar 

  30. Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115–22.

    Article  Google Scholar 

  31. Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol. 2014;6(4):135–47.

    Article  CAS  Google Scholar 

  32. Moreira AM, Marques CFS, Antunes AA, Nahas CSR, Nahas SC, De Gregorio Ariza MÁ, et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol. 2013;36(6):1690–4.

    Article  Google Scholar 

  33. Andrade G, Khoury HJ, Garzón WJ, Dubourcq F, Bredow MF, Monsignore LM, et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol. 2017;28(4):517–21.

    Article  Google Scholar 

  34. Laborda A, De Assis AM, Ioakeim I, Sánchez-Ballestín M, Carnevale FC, De Gregorio MA. Radiodermitis after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol. 2015;38(3):755–9.

    Article  Google Scholar 

  35. Miller DL, Balter S, Cole PE, Lu HT, Berenstein A, Albert R, et al. Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose. J Vasc Interv Radiol. 2003;14(8):977–90.

    Article  Google Scholar 

  36. Balter S, B a S, Miller DL, Cole PE, Lu HT, Berenstein A, et al. Radiation doses in interventional radiology procedures: the RAD-IR study. Part III: Dosimetric performance of the interventional fluoroscopy units. J Vasc Interv Radiol. 2004;15(9):919–26.

    Article  Google Scholar 

  37. Livingstone RS, Keshava SN. Technical note: reduction of radiation dose using ultrasound guidance during transjugular intrahepatic portosystemic shunt procedure. Indian J Radiol Imaging. 2011;21(1):13–4.

    Article  Google Scholar 

  38. Chida K, Kato M, Saito H, Ishibashi T, Takahashi S, Kohzuki M, et al. Optimizing patient radiation dose in intervention procedures. Acta Radiol. 2010;51(1):33–9.

    Article  Google Scholar 

  39. McQuestion M. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs. 2011;27(2):e1–17.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Justin P. McWilliams .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kao, S.D., Plotnik, A.N., McWilliams, J.P. (2020). Post-procedural Care and Complication Management for Prostatic Artery Embolization. In: Isaacson, A., Bagla, S., Raynor, M., Yu, H. (eds) Prostatic Artery Embolization. Springer, Cham. https://doi.org/10.1007/978-3-030-23471-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23471-3_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23470-6

  • Online ISBN: 978-3-030-23471-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics